Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code GOV

16. Specific lobbying issues

FDA Cannabidiol Enforcement Policy: Draft Guidance for Industry

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

HR 1175/S 362 Craft Beverage Modernization and Tax Reform Act of 2019; provisions related to craft beverage tax relief

HR 4509/S 2589 To amend the Internal Revenue Code of 1986 to restore the limitation on downward attribution of stock ownership in applying the constructive ownership rules to controlled foreign corporations, and for other purposes; all provisions of the bill

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TOB

16. Specific lobbying issues

HR 293 Youth Vaping Prevention Act of 2019; all provisions of the bill

HR 1498/S 655 SAFE Kids Act; all provisions of the bill

HR 1642/S 1965 Combating the Illicit Trade in Tobacco Products Act; all provisions of the bill

HR 1854/S 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019; all provisions of the bill

HR 2111PROTECT Act; Reducing Youth Use of E-Cigarettes Initiative; all provisions of the bill

HR 2339Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020; all provisions of the bill

HR 3942/S 1253Preventing Online Sales of E-Cigarettes to Children Act; all provisions of the bill

HR 4425Quell Underage Inhaling of Toxic Substances Act of 2019; all provisions of the bill

HR 4624 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2019; all provisions of the bill

HR 4742Protecting American Lungs Act of 2019; all provisions of the bill

HR 5721/S 3223Resources to Prevent Youth Vaping Act; all provisions of the bill

HR 5963E-Cigarette Oversight and Accountability Act of 2020; all provisions of the bill

HR 7286/S 4524 Quit Because of COVID-19; all provisions of the bill

HR 8343Independent Advisory Committee Review of E-Cigarette Applications Act; all provisions of the bill

S 616 E-Cigarette Youth Protection Act; all provisions of the bill

S 1048 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction; all provisions of the bill

S 1832 Smoke-Free Schools Act of 2019; all provisions of the bill

S 2517 Tobacco Tax Equity Act of 2019; all provisions of the bill

S 2519 Ending New Nicotine Dependencies Act of 2019 (ENND Act); all provisions of the bill

S 3174 Reversing the Youth Tobacco Epidemic Act of 2020; all provisions of the bill

ANPRMS for Docket Nos. FDA-2017-N-6189, FDA-2017-N-6565, and FDA-2017-N-6107

Proposed Rule regarding Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products

Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act

Discussions related to tobacco harm reduction

Discussions in support of the regulation of products containing synthetic nicotine

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes